Search Results for "Incruse Ellipta"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Incruse Ellipta. Results 1 to 3 of 3 total matches.
Table: Correct Use of Inhalers for COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020 (Issue 1606)
):
www.fda.gov/downloads/Drugs/DrugSafety/UCM352347.pdf
Incruse Ellipta (umeclidinium):
www.accessdata.fda.gov ...
View the Table: Correct Use of Inhalers for COPD
Comparison Table: Inhaled Drugs for Treatment of COPD (online only)
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
capsule)
2 inh once/day
512.00
460.80
527.40
Umeclidinium – Incruse Ellipta (GSK) 62.5 mcg/inh DPI (7 ...
View the Comparison Table: Inhaled Drugs for Treatment of COPD
Med Lett Drugs Ther. 2024 Sep 2;66(1710):e143-7 doi:10.58347/tml.2024.1710b | Show Introduction Hide Introduction
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
– Incruse Ellipta (GSK) 62.5 mcg/inh DPI (7, 30 inh/unit) 1 inh once/day 354.10
Inhaled Long-Acting Beta2 ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction